Ambamustine. PTT119.
D000477:Alkylating Agents / Q000009:adverse effects / Q000378:metabolism / Q000493:pharmacokinetics; D000818:Animals; D018288:Carcinoma, Small Cell / Q000188:drug therapy; D015507:Drugs, Investigational; D006801:Humans; D007275:Injections, Intravenous; D007558:Italy; D008228:Lymphoma, Non-Hodgkin / Q000188:drug therapy; D051379:Mice; D009588:Nitrogen Mustard Compounds / Q000009:adverse effects* / Q000378:metabolism / Q000493:pharmacokinetics*; D012208:Rhabdomyosarcoma / Q000188:drug therapy
D000477:Alkylating Agents; D015507:Drugs, Investigational; D009588:Nitrogen Mustard Compounds; C038259:ambamustine